Senzime AB (OSTO:SEZI) Total Equity: kr263.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SEZI Senzime AB OSTO:SEZI
71 GF Score
Price kr3.60
GF Value kr9.06
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Senzime AB Total Equity?

Senzime AB OSTO:SEZI -2.70% 71 Total Equity is kr263.8 Mil as of Jun. 2026. GuruFocus rates OSTO:SEZI with a GF Score™ of 71/100 and a GF Value™ of kr9.06 (Possible Value Trap). The stock has 3 warning signs investors should review.

Senzime AB's total equity for the quarter that ended in Jun. 2026 was kr263.8 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Senzime AB Total Equity Historical Data

* Premium members only.

The historical data trend for Senzime AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senzime AB Total Equity Chart

Senzime AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 150.58 261.90 375.48 345.86 304.46

Senzime AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 371.40 348.26 304.46 283.50 263.84
OSTO:SEZI
71GF Score
Senzime AB OSTO:SEZI
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senzime AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Senzime AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=371.08-66.619
=304.5

Senzime AB's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=325.401-61.561
=263.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr263.8 Mil mean?
Senzime AB (OSTO:SEZI) has a Total Equity of kr263.8 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Senzime AB and its competitors.
Is Senzime AB's Total Equity too high?
Senzime AB's current Total Equity is kr263.8 Mil. Overall, Senzime AB has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senzime AB's Total Equity compare to ABT and SYK?
Senzime AB's Total Equity of kr263.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Senzime AB and its competitors. Senzime AB's current Total Equity is kr263.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senzime AB stock overvalued right now?
Based on GuruFocus' analysis, Senzime AB (OSTO:SEZI) is currently considered Possible Value Trap. The stock's GF Value™ is kr9.06, compared to a current price of kr3.60 — trading 60.3% below its estimated fair value. The current Total Equity is kr263.8 Mil. Senzime AB's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Senzime AB (OSTO:SEZI), the current Total Equity is kr263.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Senzime AB (OSTO:SEZI) Overvalued in 2026?

Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued. The current stock price of kr3.60 is trading 60.3% below its estimated GF Value™ of kr9.06. GuruFocus considers Senzime AB to be Possible Value Trap.

Key valuation signals for OSTO:SEZI:

  • Total Equity: kr263.8 Mil
  • GF Value™: kr9.06 vs. price of kr3.60 (60.3% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the OSTO:SEZI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Senzime AB Business Description

Other Exchanges SNZZF:USA6YC:Germany
Address Verkstadsgatan 8, hus 1, Uppsala, SWE, 753 23
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
71GF Score

Get the complete analysis for OSTO:SEZI

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.60
Price
kr9.06
GF Value